No Data
Daga Weikang: Report for the third quarter of 2024
Vicom Ltd (301126.SZ): Its subsidiary, Jiachen Hospital, is actively promoting the application for human assisted reproduction license qualification.
Gelonghui October 11th | Dakavia vicom ltd (301126.SZ) stated at an investor relations event that its subsidiary, Jiachen Hospital, is actively promoting the application for human assisted reproduction license qualifications. Due to the high barriers of assisted reproductive technology, the lengthy licensing application process, and strict approval standards, there is uncertainty about the prospects of the company's continued assisted reproduction business.
Vicom Ltd (301126.SZ): invested 10 million yuan to establish a wholly-owned subsidiary Vicom Ltd Regenerative Medicine Research Institute.
On September 27, Gelonghui announced that in order to further meet the needs of its global strategy, enhance the company's market competitiveness, the company used its own funds to set up a wholly-owned subsidiary, Hunan Dajiaweikang Regenerative Medical Research Institute Co., Ltd. (hereinafter referred to as "Dajiaweikang Regenerative Medical Research Institute"). Recently, the Dajiaweikang Regenerative Medical Research Institute has completed the industrial and commercial registration and obtained the "Business License" issued by the Changsha County Market Supervision Administration. The establishment of this wholly-owned subsidiary will help further strengthen the company's development in the field of medical services and enhance the company's leading position in this area.
Express News | Vicom Ltd: Specific shareholders plan to reduce their shareholding by no more than 3%.
Daga Weikang: 2024 Semi-Annual Report Summary
Daga Weikang: 2024 Semi-Annual Report
No Data
No Data